Modified Folinic Acid-Fluorouracil-Oxaliplatin (FOLFOX) Followed by Capecitabine as First-line Chemotherapy for Elderly or Frail Patients With Metastatic or Recurrent Gastric Cancer
Phase of Trial: Phase IV
Latest Information Update: 04 Mar 2019
Price : $35 *
At a glance
- Drugs Capecitabine (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms MATURE
- 26 Feb 2019 Planned End Date changed from 1 May 2016 to 1 May 2022.
- 25 Feb 2019 Planned primary completion date changed from 1 Nov 2015 to 1 Nov 2021.
- 17 Dec 2013 New trial record